JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

Home・Aktien・Moleculin Biotech Inc

M
Moleculin Biotech Inc

Open

0.48 -5.88

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.43

Max

0.62

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+1350% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Nov. 2025, 21:44 UTC

Ergebnisse

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3. Nov. 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3. Nov. 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3. Nov. 2025, 23:28 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3. Nov. 2025, 23:24 UTC

Ergebnisse

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:14 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

3. Nov. 2025, 23:14 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3. Nov. 2025, 23:12 UTC

Ergebnisse

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3. Nov. 2025, 23:06 UTC

Market Talk

Ergebnisse

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3. Nov. 2025, 22:36 UTC

Market Talk

Ergebnisse

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q EPS $1.49 >FNV

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q Rev $487.7M >FNV

3. Nov. 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3. Nov. 2025, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks Agrees to Sell Stake in China Business -- WSJ

3. Nov. 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk

Ergebnisse

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

3. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. Nov. 2025, 21:49 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3. Nov. 2025, 21:40 UTC

Ergebnisse

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3. Nov. 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3. Nov. 2025, 21:19 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3. Nov. 2025, 21:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3. Nov. 2025, 21:11 UTC

Ergebnisse

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3. Nov. 2025, 21:07 UTC

Ergebnisse

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3. Nov. 2025, 21:05 UTC

Ergebnisse

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3. Nov. 2025, 21:05 UTC

Ergebnisse

Palantir Technologies 3Q Net $475.6M >PLTR

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

1350% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 1350%

Hoch 12 USD

Tief 4 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Moleculin Biotech Inc – Dist abgegeben haben.

Finanzen

Andere Aktien aus dem Sektor

JNJ

Johnson and Johnson

187.01

↓-0.37%

ABT

Abbott Laboratories

124.76

↑ +1.17%

TMO

Thermo Fisher Scientific Inc

565.5

↑ +1.94%

ISRG

Intuitive Surgical Inc

536.71

↑ +0.94%

DHR

Danaher Corp

214.8

↑ +0.69%

M Moleculin Biotech Inc

Übersicht

Veränderung der Aktienkurses

Empfehlungen

Moleculin Biotech Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

Moleculin Biotech Inc Prognose

Kursziel

Rating-Konsens

Finanzen

Andere Aktien aus dem Sektor

M
Moleculin Biotech Inc